000 04091naaaa2201081uu 4500
001 https://directory.doabooks.org/handle/20.500.12854/78746
005 20220714160655.0
020 _abooks978-3-0365-2911-0
020 _a9783036529110
020 _a9783036529103
024 7 _a10.3390/books978-3-0365-2911-0
_cdoi
041 0 _aEnglish
042 _adc
072 7 _aM
_2bicssc
100 1 _aVejux, Anne
_4edt
_91570459
700 1 _aVejux, Anne
_4oth
_91570459
245 1 0 _aCell Death, Inflammation and Oxidative Stress in Neurodegenerative Diseases : Mechanisms and Cytoprotective Molecules
260 _aBasel
_bMDPI - Multidisciplinary Digital Publishing Institute
_c2022
300 _a1 electronic resource (232 p.)
506 0 _aOpen Access
_2star
_fUnrestricted online access
520 _aNeurogenerative diseases encompass very different pathologies, which can be demyelinating or nondemyelinating, but which have common mechanisms such as cell death, oxidative stress and inflammation. A better understanding of these mechanisms allows the search for biomarkers and targets for new therapies. This special issue brings together different data on Alzheimer's disease, Parkinson's disease, and multiple sclerosis, detailing the mechanisms of cell death (necroptosis, ferroptosis), oxidative stress and inflammation but also the possibilities of neuroprotection via 5 research articles and 6 review articles. The different reviews allow us to take stock of cell death, oxidative stress and neuroinflammation in the context of neurodegenerative diseases but also in relation to other pathologies where these processes are involved.
540 _aCreative Commons
_fhttps://creativecommons.org/licenses/by/4.0/
_2cc
_4https://creativecommons.org/licenses/by/4.0/
546 _aEnglish
650 7 _aMedicine
_2bicssc
653 _aferroptosis
653 _acell death
653 _airon metabolism
653 _aneurodegenerative diseases
653 _aglutathione peroxidase 4
653 _aGSH
653 _asystem xc−
653 _aAlzheimer's disease
653 _aParkinson's disease
653 _aHuntington's disease
653 _abreast cystic fluid
653 _aclozapine
653 _aendocytosis
653 _aglia
653 _aneurons
653 _aROS
653 _aneuroprotection
653 _aneuroinflammation
653 _acatechin
653 _aL-α-phosphatidylcholine
653 _aphosphatidylserine
653 _abrain ischemia
653 _astroke
653 _amicroglia
653 _aastrocytes
653 _aT lymphocytes
653 _amonocytes
653 _aplatelets
653 _amacrophages
653 _aleukocytes
653 _aneutrophils
653 _aMPTP
653 _anecroptosis
653 _aneurodegeneration
653 _asmall molecules
653 _ahyperglycemia
653 _ahyperinsulinemia
653 _aS100B protein
653 _aoxidative stress
653 _acentral nervous system (CNS)
653 _acancer
653 _atype 2 diabetes (T2DM)
653 _aneuropsychiatric disorders
653 _amood disorders
653 _acytokines
653 _ablood-brain barrier (BBB)
653 _aFLIM
653 _abrain injuries
653 _atraumatic
653 _adiffuse axonal injury
653 _ageniculate bodies
653 _amice
653 _anerve degeneration
653 _aneurofilament proteins
653 _aneuroglia
653 _aoptic tract
653 _asuperior colliculi
653 _asynaptophysin
653 _aTDP-43 proteinopathies
653 _aapoptosis
653 _anecrosis
653 _adocosahexaenoic acid
653 _aneurodegenerative disease
653 _ainflammation
653 _ananomedicine
653 _an/a
856 4 0 _awww.oapen.org
_uhttps://mdpi.com/books/pdfview/book/4838
_70
_zDOAB: download the publication
856 4 0 _awww.oapen.org
_uhttps://directory.doabooks.org/handle/20.500.12854/78746
_70
_zDOAB: description of the publication
999 _c2978094
_d2978094